Director/PDMR Shareholding
Dechra Pharmaceuticals PLC
("the Company")
Directors / PDMR Share Dealing
2 March 2011
Dechra Pharmaceuticals PLC announces the following:
Exercise of LTIP options:
On 1 March 2011, the following Directors exercised options over ordinary shares of 1p each in the Company, granted to them on 29 February 2008 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). Each participant paid an exercise price of £1:
|
Name |
Capacity |
Options Exercised |
Shares Sold |
Sale Price per share
|
Total beneficial shareholding following this announcement |
Percentage of issued share capital |
|
Ian Page |
Director |
37,975 |
19,426 |
£5.0775 |
726,282
|
1.096% |
|
Simon Evans |
Director |
22,152 |
0 |
0 |
882,689 |
1.332% |
|
Edwin Torr |
Director |
20,253 |
10,361 |
£5.0775 |
411,381 |
0.621% |
The exercise of the LTIP options were subject to the achievement of performance conditions which were satisfied in full.
All Directors (other than Simon Evans) have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.
For further information
Zoe Goulding, Company Secretary
Telephone number: 01782 771100
This information is provided by RNS